Business Development News

Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

Fred Hutch statement regarding the FDA approval of CD19 immunotherapy, lisocabtagene maraleucel

The newly-approved CAR T-cell therapy was developed in part by Fred Hutch physician-scientists
News Releases - February 05, 2021
High-altitude altruism: Seeking cures at 17,600 feet

High-altitude altruism: Seeking cures at 17,600 feet

Fred Hutch scientist, senior leader will hike the Himalayas to raise money for cancer research
Hutch News - February 14, 2020
Fred Hutch adds senior leaders from Celgene and Amazon to board of trustees

Fred Hutch adds senior leaders from Celgene and Amazon to board of trustees

Dr. Corsee Sanders and Sean Boyle add science, technology, finance and innovation expertise to cancer research center’s board
News Releases - July 09, 2019